Streetbeat News

Price Targets

ANAB

Wedbush analyst David Nierengarten has maintained a Neutral rating on AnaptysBio (NASDAQ:ANAB) and raised the price target from $18 to $20.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:56 pm

PHVS

Wedbush analyst Laura Chico has maintained an 'Outperform' rating on Pharvaris (NASDAQ:PHVS), but lowered the price target from $27 to $24.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:50 pm

KRTX

Wedbush analyst Laura Chico maintains an Outperform rating on Karuna Therapeutics (NASDAQ:KRTX) and raises the price target from $250 to $253.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:48 pm

RKT

Wedbush analyst Jay McCanless has maintained a Neutral rating on Rocket Companies (NYSE:RKT) and lowered the price target from $11 to $8.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:45 pm

VITL

Morgan Stanley analyst Pamela Kaufman has maintained an Overweight rating on Vital Farms (NASDAQ:VITL), but lowered the price target from $20 to $18.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:43 pm

FCNCA

Wedbush analyst David Chiaverini has reiterated an Outperform rating on First Citizens BancShares (NASDAQ:FCNCA) and maintained a price target of $1800.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:43 pm

VIAV

Morgan Stanley analyst Connor Lynagh has maintained an Equal-Weight rating on Viavi Solutions (NASDAQ:VIAV) and lowered the price target from $10 to $9.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:42 pm

RARE

Morgan Stanley analyst Jeffrey Hung has maintained an 'Overweight' rating on Ultragenyx Pharmaceutical (NASDAQ:RARE) but lowered the price target from $90 to $84.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:41 pm

SRAD

Morgan Stanley analyst Connor Lynagh has maintained an Equal-Weight rating on Sportradar Gr (NASDAQ:SRAD) and lowered the price target from $11.5 to $10.5.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:39 pm

SWKS

Morgan Stanley analyst Joseph Moore has maintained an Equal-Weight rating on Skyworks Solutions (NASDAQ:SWKS) and lowered the price target from $112 to $95.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 1:37 pm